Invoking MCP tool get_variant_evidence with input {"diseaseName":"Chronic Lymphocytic Leukemia","therapyName":"Ibrutinib","significance":"RESISTANCE"}
MCP tool get_variant_evidence returned meta=None content=[TextContent(type='text', text='{
  "Field Descriptions": "evidenceType: Category describing the type of clinical or biological evidence (e.g., predictive, diagnostic).\
evidenceDirection: Indicates whether the evidence supports or refutes the association.\
significance: The clinical relevance of the evidence.\
description: Detailed summary of the evidence from CIViC curators.\
evidenceLevel: Describes the robustness of the study type. A - Validated association, B - Clinical evidence, C - Case study, D - Preclinical evidence, and E - Inferential association\
evidenceRating: Quality score assigned to the evidence by curators (scored 1-5).\
url: Direct link to the CIViC record for this evidence item.\
When returning information to users you MUST cite URLs used for specific information.",
  "API Results": [
    {
      "status": "ACCEPTED",
      "evidenceType": "PREDICTIVE",
      "evidenceDirection": "SUPPORTS",
      "significance": "RESISTANCE",
      "molecularProfile": {
        "variants": [
          {
            "name": "C481S",
            "feature": {
              "name": "BTK"
            }
          }
        ]
      },
      "disease": {
        "displayName": "Chronic Lymphocytic Leukemia"
      },
      "therapies": [
        {
          "name": "Ibrutinib"
        }
      ],
      "variantOrigin": "SOMATIC",
      "description": "Whole exome sequencing of 6 chronic lymphocytic leukemia patients with acquired resistance to ibrutinib determined 5/6 patients harbored a C481S mutation in BTK.",
      "evidenceLevel": "B",
      "evidenceRating": 4,
      "url": "https://identifiers.org/civic.eid:436"
    },
    {
      "status": "ACCEPTED",
      "evidenceType": "PREDICTIVE",
      "evidenceDirection": "SUPPORTS",
      "significance": "RESISTANCE",
      "molecularProfile": {
        "variants": [
          {
            "name": "C481S",
            "feature": {
              "name": "BTK"
            }
          }
        ]
      },
      "disease": {
        "displayName": "Chronic Lymphocytic Leukemia"
      },
      "therapies": [
        {
          "name": "Ibrutinib"
        }
      ],
      "variantOrigin": "SOMATIC",
      "description": "In a trial of 308 patients with chronic lymphocytic leukemia treated with ibrutinib, 31 discontinued treatment due to disease progression (13 CLL progression, 18 Richterâ€™s transformation). 11/13 patients were deep sequenced for BTK and PLCG2. 9 patients were identified with BTK mutations (C481S in 8 patients). In 5 patients, C481S was the sole abnormality.",
      "evidenceLevel": "B",
      "evidenceRating": 4,
      "url": "https://identifiers.org/civic.eid:1770"
    },
    {
      "status": "ACCEPTED",
      "evidenceType": "PREDICTIVE",
      "evidenceDirection": "SUPPORTS",
      "significance": "RESISTANCE",
      "molecularProfile": {
        "variants": [
          {
            "name": "T316A",
            "feature": {
              "name": "BTK"
            }
          }
        ]
      },
      "disease": {
        "displayName": "Chronic Lymphocytic Leukemia"
      },
      "therapies": [
        {
          "name": "Ibrutinib"
        }
      ],
      "variantOrigin": "SOMATIC",
      "description": "Case report of a patient with CLL and Richter-transformed relapse under ibrutinib (after an initial partial response for 10 months). Sequencing of sequential samples of this patient revealed a novel BTK T316 mutation at relapse (allele frequency of 75%). Characterization of this mutation showed that is was located on the SH2 domain, not associated with Ibrutinib binding. Introduction of this mutation in an Ibrutinib-sensitive lymphoma cell line showed resistance comparable to the known C481 resistance mutations, which was also confirmed by absence of downstream signaling.",
      "evidenceLevel": "C",
      "evidenceRating": 4,
      "url": "https://identifiers.org/civic.eid:1985"
    }
  ]
}', annotations=None, meta=None)] structuredContent=None isError=False
Invoking MCP tool get_variant_assertions with input {"diseaseName":"Chronic Lymphocytic Leukemia","therapyName":"Ibrutinib","significance":"RESISTANCE"}
MCP tool get_variant_assertions returned meta=None content=[TextContent(type='text', text='{
  "errors": [
    {
      "message": "Variable $molecularProfileName of type String! was provided invalid value",
      "locations": [
        {
          "line": 2,
          "column": 22
        }
      ],
      "extensions": {
        "value": null,
        "problems": [
          {
            "path": [],
            "explanation": "Expected value to not be null"
          }
        ]
      }
    }
  ]
}', annotations=None, meta=None)] structuredContent=None isError=False
### LLM OUTPUT ###
BTK
